In this week’s edition of InnovationRx, we look at Moderna’s use of quantum computers, a new top drug regulator at the FDA, ...

The Swiss company, which markets Elevidys abroad, said it believes the benefit-risk balance to treatment remains positive in ...

Vir Biotechnology has a strong cash position and is poised to generate definitive data in antivirals and oncology, making ...

Medically reviewed by Brendan Camp, MD Silvadene (silver sulfadiazine) cream is a topical antibacterial drug used to treat or prevent bacterial infections associated with burns. It works against a ...

The Trump Administration rolled out a plan to reign in regulations to speed up the development of AI tools and the infrastructure to power them. 'The Action Plan's objective is to articulate policy ...

Last week, the Vapor Technology Association ran ads stating its opposition to illegally imported Chinese vapes, citing the risk they pose to children, despite its leadership and the organization ...

Neuros Medical announced today that the first commercial patient in the U.S. successfully received an FDA-approved Altius ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Shares of Humacyte Inc (NASDAQ:HUMA) rose 6.1% after the company announced its first commercial sale of Symvess to a U.S.